ADVFN - ニュース

S&P 500

5,738.17

-0.13%

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/28	05 : 38	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:OLOXF	DB Crude Oil Long ETN due June 1 2038 (PK)
2024/09/28	05 : 37	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:BACRP	Bank of America Corp (PK)
2024/09/28	05 : 37	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KHC	Kraft Heinz Company
2024/09/28	05 : 36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:ARRKF	Arras Minerals Corporation (QB)
2024/09/28	05 : 36	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:KSS	Kohls Corporation
2024/09/28	05 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MTEX	Mannatech Inc
2024/09/28	05 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DD	DuPont de Nemours Inc
2024/09/28	05 : 36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:HOVVB	Hovnanian Enterprises Inc (PK)
2024/09/28	05 : 36	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 36	PR Newswire (US)	Renal Support Network to Host 31st Annual Kidney Disease Education and Lifestyle Meeting Virtually
2024/09/28	05 : 36	PR Newswire (US)	Twelve U.S. health systems receive top honor for excellence in supply chain practices from ECRI
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:GSCE	Goldman Sachs Group Inc (PK)
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:TOST	Toast Inc
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NYSE:MTAL	Metals Acquisition Limited
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:GSCE	Goldman Sachs Group Inc (PK)
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LEGN	Legend Biotech Corporation
2024/09/28	05 : 35	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:MSTLW	Morgan Stanley (PK)
2024/09/28	05 : 35	Edgar (US Regulatory)	Form N-CSR - Certified Shareholder Report	NYSE:PPT	Putnam Premier Income Trust
2024/09/28	05 : 35	GlobeNewswire Inc.	CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line	NASDAQ:LEGN	Legend Biotech Corporation